MORAb-009
Term · Oncology and biomedicine · MLC-T-ONC-005501
A substance being studied in the treatment of mesothelioma. MORAb-009 binds to a protein called mesothelin, which is found on some cancer cells. MORAb-009 may help the immune system kill cancer cells. It is a type of monoclonal antibody. Also called amatuximab and anti-mesothelin monoclonal antibody MORAb-009.
| Identifier | MLC-T-ONC-005501 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | amatuximab; anti-mesothelin monoclonal antibody MORAb-009 |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-005501",
"term": "MORAb-009",
"field": "Oncology and biomedicine",
"definition": "A substance being studied in the treatment of mesothelioma. MORAb-009 binds to a protein called mesothelin, which is found on some cancer cells. MORAb-009 may help the immune system kill cancer cells. It is a type of monoclonal antibody. Also called amatuximab and anti-mesothelin monoclonal antibody MORAb-009.",
"expansions": [
"amatuximab",
"anti-mesothelin monoclonal antibody MORAb-009"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/morab-009/"
}
Record 11,273 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.